Return to Table Selection Menu

North Dakota State Department of Health, North Dakota Statewide Cancer Registry
Cancer Mortality by Gender for Wells County , 2005-2009


Site of Cancer
Males and Females


Males


Females

Rate per 100,000 Standard Error Average Annual Cases Rate per 100,000 Standard Error Average Annual Cases Rate per 100,000 Standard Error Average Annual Cases
All Causes of Death 743.7 56.8 67 915.6 92.0 32 595.0 59.8 34
All Malignant Cancers 160.3 21.5 13 219.8 36.1 8 125.5 27.9 5
    Oral Cavity and Pharynx ^ ^ ^ ^ ^ ^ 0.0 ^ 0
        Lip 0.0 ^ 0 0.0 ^ 0 0.0 ^ 0
        Tongue 0.0 ^ 0 0.0 ^ 0 0.0 ^ 0
        Salivary Gland ^ ^ ^ ^ ^ ^ 0.0 ^ 0
        Floor of Mouth 0.0 ^ 0 0.0 ^ 0 0.0 ^ 0
        Gum and Other Mouth 0.0 ^ 0 0.0 ^ 0 0.0 ^ 0
        Nasopharynx 0.0 ^ 0 0.0 ^ 0 0.0 ^ 0
        Tonsil 0.0 ^ 0 0.0 ^ 0 0.0 ^ 0
        Oropharynx 0.0 ^ 0 0.0 ^ 0 0.0 ^ 0
            Hypopharynx 0.0 ^ 0 0.0 ^ 0 0.0 ^ 0
            Other Oral Cavity and Pharynx 0.0 ^ 0 0.0 ^ 0 0.0 ^ 0
    Digestive System 45.7 12.9 3 74.3 24.3 2 ^ ^ ^
        Esophagus ^ ^ ^ ^ ^ ^ 0.0 ^ 0
        Stomach ^ ^ ^ 0.0 ^ 0 ^ ^ ^
        Small Intestine 0.0 ^ 0 0.0 ^ 0 0.0 ^ 0
        Colon and Rectum 15.8 6.6 1 26.2 11.8 1 ^ ^ ^
            Colon excluding Rectum 15.8 6.6 1 26.2 11.8 1 ^ ^ ^
            Rectum and Rectosigmoid Junction 0.0 ^ 0 0.0 ^ 0 0.0 ^ 0
        Anus, Anal Canal and Anorectum 0.0 ^ 0 0.0 ^ 0 0.0 ^ 0
        Liver and Intrahepatic Bile Duct ^ ^ ^ ^ ^ ^ ^ ^ ^
            Liver ^ ^ ^ ^ ^ ^ ^ ^ ^
            Intrahepatic Bile Duct 0.0 ^ 0 0.0 ^ 0 0.0 ^ 0
        Gallbladder 0.0 ^ 0 0.0 ^ 0 0.0 ^ 0
        Other Biliary 0.0 ^ 0 0.0 ^ 0 0.0 ^ 0
        Pancreas ^ ^ ^ ^ ^ ^ ^ ^ ^
        Retroperitoneum 0.0 ^ 0 0.0 ^ 0 0.0 ^ 0
        Peritoneum, Omentum and Mesentery 0.0 ^ 0 0.0 ^ 0 0.0 ^ 0
        Other Digestive Organs 0.0 ^ 0 0.0 ^ 0 0.0 ^ 0
    Respiratory System 24.7 7.7 2 33.1 12.6 1 ^ ^ ^
        Nose, Nasal Cavity and Middle Ear 0.0 ^ 0 0.0 ^ 0 0.0 ^ 0
        Larynx 0.0 ^ 0 0.0 ^ 0 0.0 ^ 0
        Lung and Bronchus 24.7 7.7 2 33.1 12.6 1 ^ ^ ^
        Pleura 0.0 ^ 0 0.0 ^ 0 0.0 ^ 0
        Trachea, Mediastinum and Other Respiratory Organs 0.0 ^ 0 0.0 ^ 0 0.0 ^ 0
    Bones and Joints 0.0 ^ 0 0.0 ^ 0 0.0 ^ 0
    Soft Tissue including Heart ^ ^ ^ ^ ^ ^ ^ ^ ^
    Skin excluding Basal and Squamous 0.0 ^ 0 0.0 ^ 0 0.0 ^ 0
        Melanoma of the Skin 0.0 ^ 0 0.0 ^ 0 0.0 ^ 0
        Other Non-Epithelial Skin 0.0 ^ 0 0.0 ^ 0 0.0 ^ 0
    Breast ^ ^ ^ 0.0 ^ 0 ^ ^ ^
    Female Genital System ^ ^ ^ 0.0 ^ 0 ^ ^ ^
        Cervix Uteri 0.0 ^ 0 0.0 ^ 0 0.0 ^ 0
        Corpus and Uterus, NOS 0.0 ^ 0 0.0 ^ 0 0.0 ^ 0
            Corpus Uteri 0.0 ^ 0 0.0 ^ 0 0.0 ^ 0
            Uterus, NOS 0.0 ^ 0 0.0 ^ 0 0.0 ^ 0
        Ovary ^ ^ ^ 0.0 ^ 0 ^ ^ ^
        Vagina 0.0 ^ 0 0.0 ^ 0 0.0 ^ 0
        Vulva ^ ^ ^ 0.0 ^ 0 ^ ^ ^
        Other Female Genital Organs 0.0 ^ 0 0.0 ^ 0 0.0 ^ 0
    Male Genital System 16.7 6.1 2 38.7 13.8 2 0.0 ^ 0
        Prostate 16.7 6.1 2 38.7 13.8 2 0.0 ^ 0
        Testis 0.0 ^ 0 0.0 ^ 0 0.0 ^ 0
        Penis 0.0 ^ 0 0.0 ^ 0 0.0 ^ 0
        Other Male Genital Organs 0.0 ^ 0 0.0 ^ 0 0.0 ^ 0
    Urinary System 10.8 4.5 1 ^ ^ ^ ^ ^ ^
        Urinary Bladder ^ ^ ^ ^ ^ ^ ^ ^ ^
        Kidney and Renal Pelvis ^ ^ ^ ^ ^ ^ ^ ^ ^
        Ureter 0.0 ^ 0 0.0 ^ 0 0.0 ^ 0
        Other Urinary Organs 0.0 ^ 0 0.0 ^ 0 0.0 ^ 0
    Eye and Orbit ^ ^ ^ ^ ^ ^ 0.0 ^ 0
    Brain and Other Nervous System ^ ^ ^ ^ ^ ^ 0.0 ^ 0
    Endocrine System 0.0 ^ 0 0.0 ^ 0 0.0 ^ 0
        Thyroid 0.0 ^ 0 0.0 ^ 0 0.0 ^ 0
        Other Endocrine including Thymus 0.0 ^ 0 0.0 ^ 0 0.0 ^ 0
    Lymphoma ^ ^ ^ ^ ^ ^ ^ ^ ^
        Hodgkin Lymphoma 0.0 ^ 0 0.0 ^ 0 0.0 ^ 0
        Non-Hodgkin Lymphoma ^ ^ ^ ^ ^ ^ ^ ^ ^
    Myeloma ^ ^ ^ ^ ^ ^ 0.0 ^ 0
    Leukemia ^ ^ ^ ^ ^ ^ ^ ^ ^
        Lymphocytic Leukemia ^ ^ ^ ^ ^ ^ 0.0 ^ 0
            Acute Lymphocytic Leukemia 0.0 ^ 0 0.0 ^ 0 0.0 ^ 0
            Chronic Lymphocytic Leukemia ^ ^ ^ ^ ^ ^ 0.0 ^ 0
            Other Lymphocytic Leukemia 0.0 ^ 0 0.0 ^ 0 0.0 ^ 0
        Myeloid and Monocytic Leukemia ^ ^ ^ ^ ^ ^ ^ ^ ^
            Acute Myeloid Leukemia ^ ^ ^ ^ ^ ^ 0.0 ^ 0
            Chronic Myeloid Leukemia ^ ^ ^ 0.0 ^ 0 ^ ^ ^
            Other Myeloid/Monocytic Leukemia 0.0 ^ 0 0.0 ^ 0 0.0 ^ 0
        Other Leukemia 0.0 ^ 0 0.0 ^ 0 0.0 ^ 0
            Other Acute Leukemia 0.0 ^ 0 0.0 ^ 0 0.0 ^ 0
            Aleukemic, Subleukemic and NOS 0.0 ^ 0 0.0 ^ 0 0.0 ^ 0
    Miscellaneous Malignant Cancer 16.1 6.5 1 ^ ^ ^ ^ ^ ^
Tuberculosis 0.0 ^ 0 0.0 ^ 0 0.0 ^ 0
Human Immunodeficiency Virus (HIV) (1987+) 0.0 ^ 0 0.0 ^ 0 0.0 ^ 0
Septicemia 0.0 ^ 0 0.0 ^ 0 0.0 ^ 0
Other Infectious and Parasitic Diseases ^ ^ ^ 0.0 ^ 0 ^ ^ ^
Diabetes Mellitus 26.0 7.5 3 31.0 12.9 1 17.4 6.2 2
Alzheimers (ICD-9 and 10 only) 44.1 11.1 5 36.0 12.8 2 49.7 18.0 3
Diseases of Heart 183.2 20.7 20 211.1 32.4 9 159.0 27.9 12
Hypertension without Heart Disease 8.1 3.7 1 ^ ^ ^ ^ ^ ^
Cerebrovascular Diseases 52.0 12.1 5 46.9 17.9 2 53.9 16.0 3
Atherosclerosis 8.1 3.7 1 ^ ^ ^ ^ ^ ^
Aortic Aneurysm and Dissection ^ ^ ^ ^ ^ ^ 0.0 ^ 0
Other Diseases of Arteries, Arterioles, Capillaries ^ ^ ^ ^ ^ ^ 0.0 ^ 0
Pneumonia and Influenza 8.8 4.0 1 ^ ^ ^ ^ ^ ^
Chronic Obstructive Pulmonary Disease and Allied Cond 31.0 7.7 4 30.1 11.4 1 36.0 12.4 2
Stomach and Duodenal Ulcers 0.0 ^ 0 0.0 ^ 0 0.0 ^ 0
Chronic Liver Disease and Cirrhosis ^ ^ ^ ^ ^ ^ ^ ^ ^
Nephritis, Nephrotic Syndrome and Nephrosis ^ ^ ^ ^ ^ ^ ^ ^ ^
Complications of Pregnancy, Childbirth, Puerperium 0.0 ^ 0 0.0 ^ 0 0.0 ^ 0
Congenital Anomalies ^ ^ ^ ^ ^ ^ 0.0 ^ 0
Certain Conditions Originating in Perinatal Period 0.0 ^ 0 0.0 ^ 0 0.0 ^ 0
Symptoms, Signs and Ill-Defined Conditions ^ ^ ^ ^ ^ ^ ^ ^ ^
Accidents and Adverse Effects 115.6 39.8 4 152.3 63.5 2 64.8 30.5 1
Suicide and Self-Inflicted Injury ^ ^ ^ ^ ^ ^ 0.0 ^ 0
Homicide and Legal Intervention ^ ^ ^ ^ ^ ^ ^ ^ ^
Other Cause of Death 56.1 10.2 7 76.5 18.7 3 43.9 12.0 3

Rates are per 100,000 and age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1130) standard.
^ = Statistic could not be calculated or is not displayed due to fewer than 5 cases.